This website is intended for healthcare professionals only

Trending Topic

31 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Ventricular fibrillation (VF) is characterized by rapid (>300 beats a per minute), irregular electrical activation with variable electrocardiographic waveforms that prevents coordinated myocardial contraction, resulting in immediate loss of cardiac output.1 It most commonly occurs in the context of coronary artery disease.2,3 Resuscitation efforts are critically time-dependent: with each minute of untreated VF, the survival rate declines […]

EUROPEAN JOURNAL OF ARRHYTHMIA & ELECTROPHYSIOLOGY – VOLUME 9 SUPPLEMENT 1 – 2023

Select a Section…
1

Young Investigators Competition

2 mins
SH Man (Presenting Author) - Glenfield Hospital, Leicester, Leicester, UK; A Mavilakandy - Glenfield Hospital, Leicester, Leicester, UK; JO Ajagu - Glenfield Hospital, Leicester, Leicester, UK; R Chintalapati - Glenfield Hospital, Leicester, Leicester, UK; N Chan - Glenfield Hospital, Leicester, Leicester, UK; I Antoun - Glenfield Hospital, Leicester, Leicester, UK; M Ibrahim - Glenfield Hospital, Leicester, Leicester, UK; M Lazdam - Glenfield Hospital, Leicester, Leicester, UK; AJ Sandilands – Glenfield Hospital, Leicester, Leicester, UK; R Somani – Glenfield Hospital, Leicester, Leicester, UK; GA Ng - Glenfield Hospital, Leicester, Leicester, UK; SH Chin - Glenfield Hospital, Leicester, Leicester, UK

Background: Catheter ablation (CA) of ventricular tachycardia (VT) reduces ICD therapies in patients with VT due to structural heart disease (SHD). A structured ablation pathway may guide pre-ablation optimization of antiarrhythmic drugs (AAD) and ICD programming. We aimed to investigate impact of an ablation pathway on VT ablation outcome. Methods: The study recruited consecutive patients with SHD […]

2 mins
VS Mehta (Presenting Author) - King’s College London, London, UK; Y Ma - University of East Anglia, Coventry, UK; N Wijesuriya - King’s College London, London, UK; F DeVere - King’s College London, London, UK; MK Elliott - King’s College London, London, UK; S Howell - King’s College London, London, UK; S Niederer - King’s College London, London, UK; R Razavi - King’s College London, London, UK; CA Rinaldi - King’s College London, London, UK

Background: Risk models have been utilised to predict major adverse events (MAEs) following transvenous lead extraction (TLE). We evaluated whether applying machine learning (ML-) techniques incorporating chest radiographs increased the ability of existing models to predict MAE (defined as procedure-related major complication and procedure-related deaths). Methods: Two models were assessed whether ML would improve risk […]

2 mins
AA Miyazawa (Presenting Author) - Imperial College London, London, UK; AD Arnold - Imperial College London, London, UK; H Seligman - Imperial College London, London, UK; R Bahl - Imperial College London, London, UK; N Ali - Imperial College London, London, UK; JS Mohal - Imperial College London, London, UK; A Naraen - Imperial College London, London, UK; M Liistro - Imperial college London, London, UK; S Bangi - Imperial College London, London, UK; L Doltu - Imperial College London, London, UK; D Keene - Imperial College London, London, UK; FS Ng - Imperial College London, London, UK; NWF Linton - Imperial College London, London, UK; NS Peters - Imperial College London, London, UK; BP Lim - Imperial College London, London, UK; MJ Shun-Shin - Imperial College London, London, UK; DP Francis - Imperial College London, London, UK; R Petraco - Imperial College London, London, UK; ZI Whinnett - Imperial College London, London, UK

Background: Extending implantable cardioverter defibrillator (ICD) detection windows improves outcomes by reducing unnecessary therapies; a 1% reduction in therapies results in ~1% reduction in mortality. However, waiting too long for episodes to self-terminate may prolong cardiac ischaemia, which could compromise the effectiveness of ICD treatments. We have previously shown that laser Doppler perfusion monitoring, combined […]

2 mins
Nikhil Ahluwalia (Presenting Author) - Barts Heart Centre, London, UK; S Honarbakhsh - Barts Heart Centre, London, UK; R Hunter - Barts Heart Centre, London, UK; RJ Schilling - Barts Heart Centre, London, UK

Background: Patients with persistent atrial fibrillation (AF) may experience reduced left ventricular ejection fraction (LVEF) despite rate-control. The non-normal distribution of R–R intervals may be poorly represented by the mean heart rate and a non-parametric measure of the proportion of short R–R intervals may more sensitively characterize the AF-mediated component of left ventricular systolic dysfunction. […]

2 mins
N Jathanna (Presenting Author) - Nottingham University Hospitals NHS Trust, Nottingham, UK; Z Gong - University of Nottingham, Nottingham, UK; D Auer - University of Nottingham, Nottingham, UK; X Chen - University of Nottingham, Nottingham, UK; S Jamil-Copley - Nottingham University Hospitals NHS Trust, Nottingham, UK

Introduction: 3D models derived from late gadolinium-enhanced cardiac magnetic resonance imaging (LGE-CMR) can reduce ventricular tachycardia (VT) ablation procedure times and improve outcomes. Clinician-led manual segmentation is time and resource intensive. However, neural networks can be trained to identify and segment cardiac structures, mimicking clinician decisions, whilst operating at a fraction of the time with […]

2 mins
A Sau (Presenting Author) - Imperial College London, London, UK; AH Ribeiro - Uppsala University, Uppsala, Sweden; KA McGurk - Imperial College London, London, UK L Pastika - Imperial College London, London, UK; N Bajaj - Imperial College London, London, UK; M Ardissino - Imperial College London, London, UK; JY Chen - Imperial College London, London, UK; H Wu - Imperial College London, London, UK; X Shi - Imperial College London, London, UK; K Hnatkova - Imperial College London, London, UK; S Zheng - Imperial College London, London, UK; A Britton - University College London, London, UK; M Shipley - University College London, London, UK; I Andršová - University Hospital Brno and Masaryk University, Brno, Brno, Czech Republic; T Novotný - University Hospital Brno and Masaryk University, Brno, Brno, Czech Republic; E Sabino - University of São Paulo, São Paulo, Brazil; L Giatti - Universidade Federal de Minas Gerais, Belo Horizonte, Brazil; SM Barreto - Universidade Federal de Minas Gerais, Belo Horizonte, Brazil; JW Waks - Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, USA; DB Kramer - Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, USA; D Mandic - Imperial College London, London, UK; NS Peters - Imperial College London, London, UK; DP O’Regan - Imperial College London, London, UK; M Malik - Imperial College London, London, UK; JS Ware - Imperial College London, London, UK; ALP Ribeiro - Universidade Federal de Minas Gerais, Belo Horizonte, Brazil; FS Ng - Imperial College London, London, UK

Background: Subtle, prognostically-meaningful ECG features may not be apparent to physicians. In the course of supervised machine learning (ML) training, many thousands of ECG features are identified. These are not limited to conventional ECG parameters and morphology. These novel NN-derived ECG features may have clinical, phenotypic and genotypic associations and prognostic significance. Methods and results: […]

2

Oral Abstracts 1

2 mins
RL Warren (Presenting Author) - Northumbria Specialist Emergency Care Hospital, Newcastle upon Tyne, UK; CPJ Haslam - Northumbria Specialist Emergency Care Hospital, Newcastle upon Tyne, UK; N Campbell - Northumbria Specialist Emergency Care Hospital, Newcastle upon Tyne, UK; HE Thomas - Northumbria Specialist Emergency Care Hospital, Newcastle upon Tyne, UK

Introduction: Atrial fibrillation (AF) is the most common cardiac arrhythmia. Estimated prevalence in England is 2.5% and increases with age. It is associated with a five-fold increase in stroke risk. Anticoagulation can reduce this risk by 64%.1 Guidelines recommend anticoagulation for patients with paroxysmal or persistent AF who are at risk of stroke. The National Institute for […]

2 mins
A Bhuva (Presenting Author) - Barts Heart Centre, London, UK; N Johal - Barts Heart Centre, London, UK; B Patel - Barts Heart Centre, London, UK; B Dowsing - Barts Heart Centre, London, UK

Introduction: There are half a million people with cardiac pacemakers in the UK who are denied access to magnetic resonance imaging (MRI) when clinically indicated. Patients are fifty times less likely to be referred and there is a thirty-fold service under provision because provision is logistically difficult – it needs experts in both MRI and cardiology […]

3 mins
WTC Procter (Presenting Author) - Barts Heart Centre, London, UK; R Mravljak - Barts Heart Centre, London, UK; C Monkhouse - Barts Heart Centre, London, UK; J Bennett - Barts Heart Centre, London, UK; N Aziminia - Barts Heart Centre, London, UK; G Thornton - Barts Heart Centre, London, UK; J Elliott - Barts Heart Centre, London, UK; Z Carter - Barts Heart Centre, London, UK; T Treibel - Barts Heart Centre, London, UK; M Earley - Barts Heart Centre, London, UK

Introduction: With the ever-increasing importance of home monitoring for the follow-up of cardiac implanted electronic devices (CIED), emphasised during the COVID pandemic, the workload for CIED follow-up clinics has grown exponentially. The demand on services is exceeding resource, with innovative solutions needed to maximise efficiency, safety and quality. One potential solution has been offered by […]

2 mins
S Wildish (Presenting Author) - Trent Cardiac Centre, Nottingham City Hospital, Nottingham, UK; R Terrington - Trent Cardiac Centre, Nottingham City Hospital, Nottingham, UK; T Robinson - Trent Cardiac Centre, Nottingham City Hospital, Nottingham, UK

Background: Implantable loop recorders (ILRs) were traditionally inserted in the cardiac catheter lab on a consultant-led list. The most modern generation of devices (e.g. Medtronic LINQ II) are designed to be injected subcutaneously. The relative simplicity of the procedure brings it within the skillset of Allied Health Professionals (AHPs), freeing up medical staff, available cath lab […]

2 mins
R Macdonald (Presenting Author) - Worcestershire Acute NHS Trust, Worcester, UK

Background: Several  (ICMs) are available to enable the diagnosis and monitoring of arrhythmias. Clinicians are faced with different ICM options and must balance the workload associated with episode review alongside device performance and ensuring receipt of clinically actionable data. Objective: To compare in-time physician-adjudicated performance and clinical actionability of ICMs from different manufacturers that are currently in […]

2 mins
MC Cunha (Presenting Author) - Royal Papworth Hospital, Cambridge, UK; IT Turner - Royal Papworth Hospital, Cambridge, UK; DA Andrews - Royal Papworth Hospital, Cambridge, UK; MV Virdee - Royal Papworth Hospital, Cambridge, UK

Introduction: Right ventricular (RV) pacing, which is the standard treatment for patients with bradycardia, results in a broad QRS complex with dyssynchronous left ventricular contraction. Long-term RV pacing is associated with adverse remodelling of the left ventricular, which can contribute to, or cause, left ventricular (LV) systolic dysfunction, and heart failure (HF). A specialist clinic for […]

2 mins
M Sheikh (Presenting Author) - Milestone Pharmaceuticals, Charlotte, NC, USA; DB Bharucha - Milestone Pharmaceuticals, Charlotte, NC, USA; SD Pokorney - Duke University School of Medicine, Raleigh, NC, USA; JA Camm - St. George’s University of London, London, UK; P Dorian - Unity Health Toronto, Toronto, ON, Canada; JE Ip - Weill Cornell Medicine, New York Presbyterian Hospital, New York, NY, USA; PR Kowey - Main Line Health, Wynnewood, PA, USA; BS Stambler - Piedmont Healthcare, Atlanta, GA, USA; JP Piccini - Duke University School of Medicine, Durham, NC, USA

Objectives: Paroxysmal supraventricular tachycardia (PSVT) causes economic burden due to a frequent need for medical interventions and emergency department (ED) visits with substantial costs. The NODE-301 study evaluated the efficacy and safety of the novel, fast-acting, investigational intranasal calcium channel blocker etripamil for conversion of PSVT in an at-home setting. This analysis assessed the impact of […]

2 mins
Johanna Tonko (Presenting Author) – University College London, London, UK; AL Lee – Kings College London, London, UK; JW Whitaker – Kings College London, London, UK

Introduction: Contemporary imaging methods allow to assess structural alterations implicated in initiation and maintenance of AF. It is thought that left atrial wall thickness (LAWT) increases in the presence of AF and may further promote its perpetuation. Tissue thickness may also be important to the success and safety of AF ablation to create transmural lesions without […]

2 mins
S Raman (Presenting Author) - Freeman Hospital, Newcastle Upon Tyne, UK; P Rutherford - Freeman Hospital, Newcastle Upon Tyne, UK; M Das - Freeman Hospital, Newcastle Upon Tyne, UK

Background: Direct current electrical cardioversion (DCCV) is utilized for managing patients with symptomatic persistent atrial fibrillation (AF) as part of a rhythm-control strategy. Rates of acute conversion and maintenance of sinus rhythm (SR) following DCCV improve with concomitant use of anti-arrhythmic drugs (AAD) such as amiodarone, which has the greatest efficacy amongst various agents, albeit with […]

2 mins
Cho Thazin Aye (Presenting Author) - University Hospitals Plymouth NHS Trust, Plymouth, UK; Guy Haywood - University Hospitals Plymouth NHS Trust, Plymouth, UK

Introduction: Atrial fibrillation (AF) is the most common cardiac arrhythmia and the prevalence is increasing every year, especially for persistent atrial fibrillation. The evidence base for rhythm control strategies in persistent atrial fibrillation remains contentious. Cryoballoon ablation is one of the conventional rhythm-control therapies in treatment-resistant AF, and has emerged as a successful therapeutic option as […]

2 mins
SS Kumar (Presenting Author) - University of Cambridge, Cambridge, UK; H Raju - St. George’s Hospital, London, UK; S Sharma - St. George’s Hospital, London, UK; E Behr - St. George’s Hospital, London, UK; G Mellor - Royal Papworth Hospital, Cambridge, UK

Introduction: ECG changes diagnostic for Brugada syndrome may be precipitated by sodium channel blocker (SCB) challenge. The SCB ajmaline has been demonstrated to be an effective pharmacological agent of choice. Published studies recommend a dose of 1 mg/kg bodyweight (maximum 100 mg) given either as a continuous infusion or by repeated boluses at 10 mg/minute intervals. […]

2 mins
S Kuriakose (Presenting Author) - Barking, Havering and Redbridge University Hospitals NHS Trust, Romford, UK; W Read - Barking, Havering and Redbridge University Hospitals NHS Trust, Romford, UK; A Baldwin - Havering Primary Care Trust, Romford, UK; D Sinha - Barking Havering and Redbridge University Hospitals NHS Trust, Romford, UK; A Sohaib - Barking Havering and Redbridge University Hospitals NHS Trust, Romford, UK; S Evens - Qompium, Hasselt, Belgium; J Kidd - North East London Health and Care Partnership, London, UK

Background: Atrial fibrillation (AF) is a prevalent cardiac arrhythmia linked with a five-fold increased risk of ischaemic stroke. Despite the need for pulse rhythm checks of reasonable duration in selectively identified high-risk patients, the NHS is under pressure to perform these tasks to prevent stroke during daily practice in primary care. Purpose: This program aimed to establish […]

3

Oral Abstracts 2

2 mins
VS Savickas (Presenting Author) - University of East Anglia, Norwich, UK; CW Wright - University of East Anglia, Norwich, UK; AL Leggett - University of East Anglia, Norwich, UK; YN Nuako - University of East Anglia, Norwich, UK

Introduction: Atrial fibrillation (AF) increases the risk of stroke by up to five-fold and costs the UK economy £2 billion per year. Direct-acting oral anticoagulants (DOACs) or vitamin K antagonists (VKAs) are offered to eligible individuals to reduce their thromboembolic risk, yet are not suitable for all patients, for instance due to significant drug–drug interactions. Off-label […]

2 mins
C Sohrabi (Presenting Author) - Barnet Hospital, Royal Free London NHS Foundation Trust, London, UK; N Papageorgiou - Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; JSC Del Mundo - Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; N Aziminia - Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; K Mouyis - Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; PD Lambiase - Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; S Ahsan - Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; P Moore - Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; M Dhinoja - Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; S Sporton - Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; MJ Earley - Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; RJ Schilling - Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; C Hayward - Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; R Providencia - Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; R Hunter - Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; AW Chow - Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; A Muthumala - Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK

Introduction: Cardiac resynchronization therapy (CRT) is widely used for the management of patients with heart failure (HF) and severe left ventricular (LV) systolic dysfunction with a wide QRS duration.1 However, there is currently limited evidence on its effectiveness in patients with atrial fibrillation (AF). The purpose of this study is to investigate response to CRT in […]

2 mins
Mohamed Ali (Presenting Author) - Barts Heart Centre, London, UK; Christopher Monkhouse - Barts Heart Centre, London, UK; R Lamelas - Barts Heart Centre, London, UK; L Sevier - Barts Heart Centre, London, UK; S Martin - Barts Heart Centre, London, UK; S Whittaker-Axon - Barts Heart Centre, London, UK; J Malcolmson - Barts Heart Centre, London, UK; E Maclean - Barts Heart Centre, London, UK; A Dennis - Barts Heart Centre, London, UK; J Tsonko - Barts Heart Centre, London, UK; C Primus - Barts Heart Centre, London, UK; J Zhang - Barts Heart Centre, London, UK; M Thomas - Barts Heart Centre, London, UK; M Dhinoja - Barts Heart Centre, London, UK

Introduction: Ventricular tachycardia (VT) is a potentially life-threatening arrhythmia that can be caused by many factors, such as the patients’ underlying cardiac condition and importantly the cardiac scar. However, initiation of VT can be multi-factorial, and be associated with other factors, such as lifestyle, glycaemic control and respiratory disease. An implantable cardioverter defibrillator (ICD) is […]

2 mins
Miss Selvarajah (Presenting Author) – King’s College Hospital, London, UK; Mrs Khan – King’s College Hospital, London, UK; Mr Jahagirdar – King’s College Hospital, London, UK; Dr Cannata – King’s College Hospital, London, UK; Dr Mukherjee – King’s College Hospital, London, UK; Dr Bromage – King’s College Hospital, London, UK; Dr McDonagh – King’s College Hospital, London, UK; Dr Murgatroyd – King’s College Hospital, London, UK; Dr Scott – King’s College Hospital, London, UK

Background: In patients presenting following a first implantable cardioverter defibrillator (ICD) therapy, the risk of a subsequent ICD therapy is elevated. The most effective way to treat these patients is unknown. We hypothesised that in patients presenting following their first ICD therapy, a multifaceted approach combining treatment strategies would lead to a reduction in the risk […]

2 mins
LP Libor Pastika (Presenting Author) - Imperial College London, London, UK; AS Sau - Imperial College London, London, UK; ES Sieliwonczyk - Imperial College London, London, UK; KP Patlatzoglou - Imperial College London, London, UK; JYC Chen - Imperial College London, London, UK; AHR Ribeiro - Uppsala University, Uppsala, Sweden; SK Khan - Imperial College Healthcare NHS Trust, London, UK; JWW Waks - Beth Israel Deaconess Medical Center, Boston, MA, USA; DBK Kramer - Beth Israel Deaconess Medical Center, Boston, MA, USA; DM Mandic - Imperial College London, London, UK; NSP Peters - Imperial College London, London, UK; JSW Ware - Imperial College London, London, UK; ALPR Ribeiro - Universidade Federal de Minas Gerais, Belo Horizente, Brazil; FNG Ng - Imperial College London, London, UK

Background: Obesity-related cardiac remodelling may be reflected through electrocardiogram (ECG) changes. Based on this premise, we hypothesised that an artificial intelligence (AI)-ECG model could be trained to predict body mass index (BMI), and that the difference between AI-ECG predicted BMI and measured BMI (delta BMI) would be a marker of cardiometabolic health. Additionally, we sought to […]

2 mins
C Monkhouse (Presenting Author) - Barts Heart Centre, London, UK; J Elliott - Barts Heart Centre, London, UK; S Whittaker-Axon - Barts Heart Centre, London, UK; J Collinson - Barts Heart Centre, London, UK; AW Chow - Barts Heart Centre, London, UK; P Moore - Barts Heart Centre, London, UK; A Muthumala - Barts Heart Centre, London, UK; S Honarbakhsh - Barts Heart Centre, London, UK; R Hunter - Barts Heart Centre, London, UK; PD Lambiase - Barts Heart Centre, London, UK; S Ahsan - Barts Heart Centre, London, UK; Simon Sporton - Barts Heart Centre, London, UK

Introduction: The increasing use of remote monitoring (RM) for implantable cardiac devices presents challenges for device services in managing the volume and nature of information received. Detecting a patient’s death through RM transmissions is a significant but infrequent event. This study aims to describe the characteristics of alert transmissions indicating the possibility of death and propose […]

2 mins
Nikhil Ahluwalia (Presenting Author) - Barts Heart Centre, London, UK; S Honarbakhsh - Barts Heart Centre, London, UK; R Hunter - Barts Heart Centre, London, UK; RJ Schilling - Barts Heart Centre, London, UK

Background: Periodic breathing pattern is a poor prognostic factor of advanced systolic heart failure (HF). It can manifest as exercise-induced oscillatory ventilation (EOV) on cardio-pulmonary exercise testing (CPET); a result of impaired homeostasis. Atrial fibrillation (AF) is also associated with exertional dyspnoea and EOV has not been described in patients with AF and HF. Objective: To report […]

2 mins
Ovais Ahmed Jaffery (Presenting Author) - Queen Mary University of London, London, UK; Caterina Vidal Horrach - Queen Mary University of London, London, UK; Daniel J. Lagalante - Acutus Medical, Carlsbad, CA, USA; George Thomas - Weill Cornell Medicine, New York City, NY, USA; Greg Slabaugh - Digital Environment Research Institute (DERI), London, UK; Wilson W Good - Acutus Medical, Carlsbad, California, CA, USA; Caroline H Roney - Queen Mary University of London, London, UK

Background: Improving outcomes with ablation of non-paroxysmal AF has proved challenging because of large interindividual variability in the underlying electrical and anatomical substrate. Computational models personalized to patient electroanatomic mapping (EAM) data can provide an inexpensive technology to predict outcomes for non-PV ablation strategies in terms of success, failure or reduced AF complexity on a patient-specific […]

2 mins
CE Lopez-Barrera (Presenting Author) - Queen Mary University of London, London, UK; C Roney - Queen Mary University of London, London, UK; CR Santillan-Rodriguez - Centro de Investigacion en Materiales Avanzados, Chihuahua, Mexico

Background: The spatial resolution of a mapping catheter is determined by factors such as the quantity of electrodes, their inter-electrode spacing, and the various configurations in which they are utilized. These factors impact the interpretation of wavefront dynamics during cardiac arrhythmias. Virtual patient models incorporating simulated arrhythmias offer an ideal dataset for evaluating the spatial resolution […]

2 mins
SB Misghina (Presenting Author) - Queen Mary University of London, London, UK; JA Solis-Lemus - King’s College London, London, UK; EJ Vigmond - University of Bordeaux, Bordeaux, France; SA Niederer - King’s College London, London, UK; CH Roney - Queen Mary University of London, London, UK

Introduction: Recent clinical and mechanistic modelling studies have identified the significance of the right atrium (RA) in understanding the mechanisms underlying atrial fibrillation (AF) recurrence, though its role for each individual patient remains unclear. Predicting patient-specific response to treatment to guide therapy requires a framework for integrating personalised anatomy, fibrosis, and electrophysiology data. The first aim […]

2 mins
S Honarbakhsh (Presenting Author) - St Bartholomew’s Hospital, Barts Heart Centre, Barts Health NHS Trust, London, UK; C Roney - Queen Mary University of London, London, UK; C Vidal Horrach - Queen Mary University of London, London, UK; A Wharmby - St Bartholomew’s Hospital, Barts Heart Centre, Barts Health NHS Trust, London, UK; PD Lambiase - St Bartholomew’s Hospital, Barts Heart Centre, Barts NHS Trust, London, UK; RJ Hunter - St Bartholomew’s Hospital, Barts Heart Centre, Barts Health NHS Trust, London, UK

Introduction: Scar and autonomic remodelling are proposed pathophysiological mechanisms in atrial fibrillation (AF). Autonomic remodelling has been shown to trigger ectopy that initiates AF. In animal models, autonomic remodelling shortens the atrial effective refractory period and wavelength of the cardiac impulse, which in turns increases the probability of multiple re-entrant circuits existing simultaneously and thereby enhance […]

4

Oral Abstracts 3

Background: The way that dual chamber pacemakers are programmed can affect the estimated battery longevity. This remaining battery life is calculated by the device itself; it is unknown how specific variables such as reduced ventricular pacing modes/algorithms and rate response effect the estimated battery longevity. This therefore forms the primary aim of this study. Whilst current […]

< 1 min
H Willis (Presenting Author) – Northwick Park Hospital, London, UK; JR Griffiths – Glenfield Hospital Leicester, Leicester, UK; S Hussain – Glenfield Hospital Leicester, Leicester, UK; R Somani – Glenfield Hospital Leicester, Leicester, UK

Background: Twiddler syndrome, and the variant Reel syndrome, are rare but important complications of pacemaker implantation. Case summary: We describe a rare complication of conventional permanent pacemaker implantation of rhythmic arm twitching secondary to brachial plexus stimulation from a displaced pacing lead caused by Reel syndrome. Discussion: Twiddler syndrome and its variants are rare but important complications of […]

2 mins
Vikas Kataria (Presenting Author) – Holy Family Hospital, New Delhi, India; Amitabh Yaduvanshi – Holy Family Hospital, New Delhi, India; Mohit Bhagwati – Holy Family Hospital, New Delhi, India

Background and objectives: Cardiac resynchronization therapy (CRT) using bi-ventricular pacing is class I recommendation for symptomatic patients with heart failure (LVEF ≤35%), QRS duration ≥150 msec and LBBB QRS morphology. Left bundle branch area pacing (LBBAP) has been reported as an alternative option for CRT. The aim of this study was to assess the feasibility and […]

2 mins
TS Su (Presenting Author) – Glenfield Hospital, Leicester, UK; R Chelliah – Glenfield Hospital, Leicester, UK; R Pathmanathan – Glenfield Hospital, Leicester, UK; R Somani – Glenfield Hospital, Leicester, UK

Introduction: Transcatheter leadless pacemakers are increasingly being used for the treatment of bradyarrhythmia. Data following conventional transvenous pacemaker implantation suggests same-day discharges are safe and have become the standard of care in many institutions around the world. There is limited data regarding same-day discharges in patients undergoing leadless pacemaker implantation. Purpose: To assess the feasibility and safety […]

2 mins
R Cemin (Presenting Author) – Ospedale Regionale San Maurizio, Bolzano, Italy; B Baldauf – CAU and University of Applied Sciences Bremerhaven, Kiel, Germany; S Borov – CAU and Klinikum Freising, Kiel, Germany; M Giaccardi – SMA, Firenze, Italy; EW Lau – RVH, Belfast, Northern Ireland; P Chevalier – HCL Louis Pradel, Lyon, France; O Assadian – LKWN, Wiener Neustadt, Austria; R Vonthein – IMBS, Luebeck, Germany; H Bonnemeier – CAU, University of Applied Sciences Bremerhaven, Helios Cuxhaven and Nordenham, Cuxhaven, Germany

Introduction: With advances in cardiac resynchronisation therapy (CRT) equipment and operator experience, implant success is increasing. However, the commonest cause for procedural failure remains a lack of suitable pacing site due to an absent or insufficiently sized target vein. The role of computed tomography (CT) prior to CRT remains investigational, but improved imaging techniques allow […]

2 mins
RL Meyrick (Presenting Author) – University Hospital Plymouth, Plymouth, UK; BJ Sieniewicz – University Hospital Plymouth, Plymouth, UK; S Merson – University Hospital Plymouth, Plymouth, UK

Introduction: The use of remote monitoring (RM) to undertake cardiac implantable electronic device (CIED) follow-up is becoming increasingly common, particularly following the COVID-19 pandemic. This method of CIED assessment has been shown to be non-inferior to face-to-face only assessments. Purpose: We sought to assess the safety of adopting a strategy of alert based follow up in selected […]

2 mins
J Grade Santos (Presenting Author) – Liverpool Heart and Chest Hospital, Liverpool, UK; P Calvert – Liverpool Heart and Chest Hospital, Liverpool, UK; N Worthington – Abbott, Liverpool, UK; C Phenton – Abbott, Liverpool, UK; R Ashrafi – Liverpool Heart and Chest Hospital, Liverpool, UK; S Modi – Liverpool Heart and Chest Hospital, Liverpool, UK; S Mahida – Liverpool Heart and Chest Hospital, Liverpool, UK; D Gupta – Liverpool Heart and Chest Hospital, Liverpool, UK; D Todd – Liverpool Heart and Chest Hospital, Liverpool, UK; J Waktare – Liverpool Heart and Chest Hospital, Liverpool, UK; V Luther – Liverpool Heart and Chest Hospital, Liverpool, UK

Introduction: Understanding post-infarct VT substrate relies on a combination of voltage and activation mapping. These maps are often analysed separately. Omnipolar electrograms (Omni-EGMs) offer a novel approach to mapping, with local activation displayed as a vector. We describe an approach to characterize the post-infarct ventricular arrhythmic substrate using omni-vectors superimposed onto omni-voltage maps for review ‘in […]

2 mins
Mahmoud Ehnesh (Presenting Author) – Queen Mary University of London, London, UK; Xin Li – University of Leicester, Leicester, UK; Alexander M. Zolotarev – Queen Mary University of London, London, UK; Tiago P. Almeida – University of Leicester, Leicester, UK; Fernando S. Schlindwein – University of Leicester, Leicester, UK; Caroline Roney – Queen Mary University of London, London, UK; G. André Ng – University of Leicester, Leicester, UK

Introduction: Identifying ablation targets for persistent atrial fibrillation (PersAF) remains challenging. Dominant frequency (DF) and organization index (OI) of atrial electrograms (AEGs) are proposed to identify driver sites that contribute to AF perpetuation. This work aims to use DF and OI together to identify atrial regions with organised, fast activation rates based on electrophysiologic responses following […]

2 mins
Ioanna Koniari (Presenting Author) – Liverpool Heart and chest Hospital, Liverpool, UK; Peter Calvert – Liverpool Heart and chest Hospital, Liverpool, UK; Reza Ashrafi – Liverpool Heart and chest Hospital, Liverpool, UK; Richard Snowdon – Liverpool Heart and chest Hospital, Liverpool, UK; Dhiraj Gupta – Liverpool Heart and chest Hospital, Liverpool, UK; Vishal Luther – Liverpool Heart and chest Hospital, Liverpool, UK

Introduction: Very high power, short duration ablation (Vhpsd) involves using radiofrequency (RF) ablation powers of 90 W for just 4 seconds per lesion, delivered using the Q-DOT ablation catheter (Biosense Webster). We have shown how shorter ablation lesions improve patient comfort during pulmonary vein isolation (PVI) and may obviate the need for general anaesthesia. It is […]

< 1 min
LCB Martins (Presenting Author) – Heart Institute Sao Paulo, Sao Paulo, Brazil; CF Pisani – Heart Institute Sao Paulo, Sao Paulo, Brazil; FK Dorfman – Heart Institute Sao Paulo, Sao Paulo, Brazil; FC Darrieux – Heart Institute Sao Paulo, Sao Paulo, Brazil; TC Wu – Heart Institute Sao Paulo, Sao Paulo, Brazil; DT Hachul – Heart Institute Sao Paulo, Sao Paulo, Brazil; CC Castro – Heart Institute Sao Paulo, Sao Paulo, Brazil; RR Prado – Heart Institute – Sao Paulo, Sao Paulo, Brazil; LVF Souza – Heart Institute Sao Paulo, Sao Paulo, Brazil; L Sacilloto – Heart Institute Sao Paulo, Sao Paulo, Brazil; GDA Pessente – Heart Institute Sao Paulo, Sao Paulo, Brazil; CJ Gruppi – Heart Institute Sao Paulo, Sao Paulo, Brazil; MO Chorkr – Heart Institute – Sao Paulo, Sao Paulo, Brazil; CH Nomura – Heart Institute – Sao Paulo, Sao Paulo, Brazil; KR Oliveira – Heart Institute – Sao Paulo, Sao Paulo, Brazil; CP Balbo – Heart Institute – Sao Paulo, Sao Paulo, Brazil; SL Melo – Heart Institute – Sao Paulo, Sao Paulo, Brazil; P Veronese – Heart Institute – Sao Paulo, Sao Paulo, Brazil; MI Scanavacca – Heart Institute – Sao Paulo, Sao Paulo, Brazil; AP Ferraz – Heart Institute Sao Paulo, Sao Paulo, Brazil

Aims: Compare catheter ablation (CA) using second-generation pulmonary vein ablation catheter (PVAC) gold technique with clinical treatment in elderly patients with symptomatic paroxysmal AF (PAF), without structural heart diseases. Methods: Prospective randomized study selected consecutive patients with paroxysmal AF ≥65 years in 2 groups: (1) the PVAC CA group and (2) the antiarrhythmic drug (AAD) therapy group. […]

3 mins
Johanna Tonko (Presenting Author) – University College London, London, UK; MT Tourni – Columbia University, New York City, NY, USA; EK Konofagou – Columbia University, New York City, NY, USA; PL Lambiase – University College London, London, UK

Introduction: The restriction of activation mapping to the ventricular surface of contemporary mapping systems often leads to failure to correctly identify the true site of origin (SOO) of intramural and/or sub-epicardial Vas and lower procedural success. Electromechanical wave imaging (EWI) is a non-invasive echocardiography-based high frame rate technology that offers direct transmural activation mapping and may […]

5

Moderated Posters 1

2 mins
AJ Griffiths (Presenting Author) – Oxford University NHS Foundation Trust and Oxford Brookes University, Oxford, UK; E Watson – Oxford Brookes University, Oxford, UK; Helen Walthall – Oxford University NHS Foundation Trust, Oxford, UK; L Stayt – Oxford Brookes University and Oxford University NHS Foundation Trust, Oxford, UK

Atrial fibrillation (AF) is the most common arrhythmia seen in clinical practice. Previous studies have demonstrated that AF may result in high symptom burden and reduced quality of life (QoL). Rhythm control in the form of catheter ablation has become an established treatment option for AF. Certain risk factors are associated with the development and […]

2 mins
N Papageorgiou – Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; C Sohrabi (Presenting Author) – Barnet Hospital, Royal Free London NHS Foundation Trust, London, UK; C Bakogiannis – 3rd Cardiology Department, Ippokrateion Hospital, Thessaloniki, Greece; A Tsarouchas – 3rd Cardiology Department, Ippokrateion Hospital, Thessaloniki, Greece; K Kukendrarajah – The Farr Institute of Health Informatics Research, University College London, London, UK; L Matiti – Broomfield Hospital, Mid and South Essex NHS Foundation Trust, Essex, UK; NT Srinivasan – Department of Cardiac Electrophysiology, Essex Cardiothoracic Centre, Basildon, UK; Syed Ahsan – Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; S Sporton – Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; RJ Schilling – Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; R Hunter – Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; A Muthumala – Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; A Creta – Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; AW Chow – Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK; R Providencia – Electrophysiology Department, Barts Heart Centre, St Bartholomew’s Hospital, London, UK

Introduction: The relationship between ABO blood group and Rhesus status with survival outcomes in patients with heart failure (HF) managed with CRT-P/D remains unclear. Understanding this association could provide valuable insights for developing innovative therapeutic approaches, guiding risk-stratification methods, and predicting clinical response to treatment. This retrospective single-centre observational study aimed to evaluate the role […]

2 mins
Christopher Monkhouse (Presenting Author) – Barts Heart Centre, London, UK; S Fazil – Barts Heart Centre, London, UK; J Binoy – Barts Heart Centre, London, UK; Helen Harvie – Barts Heart Centre, London, UK; H Granville – Barts Heart Centre, London, UK; R Hunter – Barts Heart Centre, London, UK; PD Lambiase – Barts Heart Centre, London, UK; R Providencia – Barts Heart Centre, London, UK; S Ahsan – Barts Heart Centre, London, UK; MJ Earley – Barts Heart Centre, London, UK

Introduction: Over the past 10 years, the indications for implantable loop recorder (ILR) have broadened and the device size has reduced substantially. The implant procedure has moved from the physician-led catheter-lab environment to non-physician-led outpatient procedures. ILR explant procedures have not transitioned in parallel. We implemented a non-physician, outpatient ILR explant service in 2021 and […]

2 mins
Authors: PS Stamatakos (Presenting Author) – Croydon University Hospital, London, UK; BS Sidhu – Croydon University Hospital, London, UK; SW Wilson – Croydon University Hospital, London, UK; PA Arumugam – Croydon University Hospital, London, UK; JM McNicholas – Croydon University Hospital, London, UK; DD Dedios – Croydon University Hospital, London, UK; GK Kelly – Croydon University Hospital, London, UK; AR Raveendran – Croydon University Hospital, London, UK; HS Shabeeh – Croydon University Hospital, London, UK; RK Kamdar – Croydon University Hospital, London, UK

Background: Conduction system pacing is a novel pacing technique that aims to maintain physiological activation of the ventricles. It can be achieved by pacing the His-bundle or the left bundle branch area. Left bundle branch area pacing (LBBAP) has many advantages over His-bundle pacing including being technically easier and having more stable and lower thresholds. […]

2 mins
Authors: SG Gohel (Presenting Author) – KCH, London, UK; PK Khan – KCH, London, UK; PS Stamatakos – CUH, London, UK; BS Sidhu – CUH, London, UK; PS Scott – KCH, London, UK; RK Kamdar – CUH, London, UK

Background: Conduction system pacing has the potential to offer improved outcomes compared with other forms of pacing. His bundle pacing (HBP) can be technically more difficult to achieve and pacing thresholds can be unreliable compared with left bundle branch area pacing (LBBAP). There are no reports describing the feasibility of performing both procedures in the […]

2 mins
Authors: ALW Wharmby (Presenting Author) – St Bartholomew’s Hospital, London, UK; VE Ezzat – St Bartholomew’s Hospital, London, UK; HD Daw – St Bartholomew’s Hospital, London, UK; ML Lowe – St Bartholomew’s Hospital, London, UK; VS Sawhney – St Bartholomew’s Hospital, London, UK

Background: Patients with adult congenital heart disease (ACHD) are more prone to atrial arrhythmia, which increases their morbidity and mortality and risk of hospital admissions when compared with the same population where atrial arrhythmias are absent. Objective: Compare the use of OCTARAY™ to PENTARAY™ for atrial tachycardia mapping in a patient with ACHD to understand […]

2 mins
Authors: KE Eptlett (Presenting Author) – Royal Stoke University Hospital, Stoke-on-Trent, UK; JM Mayer – Royal Stoke University Hospital, Stoke-onTrent, UK; VW Walker – Royal Stoke University Hospital, Stoke-On-Trent, UK; IN Natarajan – Royal Stoke University Hospital, Stoke-on-Trent, UK; AP Patwala – Royal Stoke University Hospital, Stoke-On-Trent, UK; TP Phan – Royal Stoke University Hospital, Stoke-On-Trent, UK

Introduction: Cryptogenic stroke (CS) accounts for 30–40% of all ischaemic strokes and there is substantial evidence to suggest arrhythmogenic cardioembolic involvement following the development of atrial fibrillation (AF). CS related to AF are often devastating, with around 70% mortality or significant disability. CS recurrence in the context of AF can be reduced with initiation of […]

2 mins
Authors: HR Eftekhari (Presenting Author) – University of Warwick and University Hospitals Coventry and Warwickshire, Coventry, UK; G Pearce – Coventry University, Coventry, UK; S Staniszweska – University of Warwick, Coventry, UK; K Seers – University of Warwick, Coventry, UK

Introduction: Crucial for future healthcare delivery is supporting people in self-management. Postural tachycardia syndrome (PoTS) is considered to be underdiagnosed and under-treated, yet has a high impact on disability and quality of life comparable to other long-term conditions. This study addresses the gap for a PoTS-specific supportive self-management programme. The aim was to co-design and […]

2 mins
Authors: M Patel (Presenting Author) – Barts Health NHS Trust, London, UK; S Ali – Southdene Surgery, London, UK; R Clements – North East London Integrated Care Board, London, UK; J Robson – Clinical Effectiveness Group University of London, London, UK; R Patel – Barts Health NHS Trust, London, UK; J Chahal – Barts Health NHS Trust, London, UK; S Antoniou – Barts Health NHS Trust, London, UK; P Wright – Barts Health NHS Trust, London, UK

Background: The National Institute for Health and Care Excellence (NICE) guidelines for atrial fibrillation (AF) diagnosis and management 2021 recommends offering patients with AF and a CHA2DS2VASc >2 anticoagulation with a direct-acting oral anticoagulant (DOAC) first line where appropriate for stroke prevention. For patients on vitamin-K antagonists, their anticoagulation control is assessed according to time […]

6

Moderated Posters 2

2 mins
Authors: MA Sammut (Presenting Author) – Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK; R Oatham – Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK; M Mills – Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK; H Zafar – Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK; P Garg – Norfolk and Norwich University Hospital, Norwich, UK; J Lee – Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK; N Kelland – Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK; J Sahu – Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK; G Kirkwood – Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK; P Metherall – Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK; S Whiteman – Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK; G Smith – Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK; A Kyriacou – Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK

Background: Catheter ablation is an effective therapy for ventricular tachycardia (VT) secondary to ischaemic heart disease (IHD), but its wider adoption is limited by procedure complexity and safety. Pre-procedural planning with cardiac computer tomography (CT) or magnetic resonance (MR) and their integration into electro-anatomical mapping (EAM) during ablation have sought to address some of the […]

2 mins
J McIntyre (Presenting Author) – University Hospital North Midlands NHS Trust, Stoke-on-Trent, UK

Background: Radiation therapy (RT) is a standard modality for cancer treatment for patients with cardiac implantable electronic devices (CIEDs). The increased ageing population has influenced the number of patients receiving radiation therapy, and concurrently the number of patients undergoing implantation of CIEDs. Identification of risk factors and safety concerns for RT to CIEDs must therefore […]

3 mins
LR Moore (Presenting Author) – Manchester University NHS Foundation Trust, Manchester, UK; A Domingos – Manchester University NHS Foundation Trust, Manchester, UK

Introduction: Cardiac implantable electronic device (CIED) diagnostics are of significant clinical utility when managing the heart failure (HF) population. This report highlights a novel service in which cardiac physiologists act autonomously upon CIED diagnostics to identify and manage patients at risk of decompensated HF. Patient presentation: A 71-year-old female with ischaemic heart disease and paroxysmal atrial […]

2 mins
S Borov (Presenting Author) – CAU and Klinikum Freising, Kiel, Germany; B Baldauf – CAU and HS Bremerhaven, Kiel, Germany; M Giaccardi – SMA, Firenze, Italy; EW Lau – RVH, Belfast, UK; R Cemin – RSM, Bolzano, Italy; P Chevalier – HLP, Lyon, France; O Assadian – LKWN, Wiener Neustadt, Austria; R Vonthein – IMBS, Luebeck, Germany; H Bonnemeier – CAU; Helios Cuxhaven; Helios Nordenham, HS Bremerhaven, Kiel, Germany

Introduction: The rate of cardiac implantable electronic device (CIED) placement is increasing. CIED placement comes with complications. CIED infection is a major complication increasing both morbidity and mortality. International guidelines do not recommend the local use of specific antimicrobial agents during implantation because adequate scientific studies supporting their use are not available or not supportive. In […]

2 mins
MJ Hogg (Presenting Author) – Department of Social Work, Education and Community Wellbeing, Northumbria University, Newcastle Upon Tyne, UK; J McCready – Department of Social Work, Education and Community Wellbeing, Northumbria University, Newcastle Upon Tyne, UK; V Deary – Department of Psychology, Northumbria University, Newcastle Upon Tyne, UK; JL Newton – Population Health Science Institute, The Medical School, Newcastle University, Newcastle Upon Tyne, UK; T Rapley – Department of Social Work, Education and Community Wellbeing, Northumbria University, Newcastle Upon Tyne, UK

Aim: This scoping review examined the key characteristics of empirical research and their clinical implications pertaining to diagnosis, symptomology and treatment across the postural tachycardia syndrome (PoTS) literature field. Methods: An a priori protocol, article eligibility criteria and peer-reviewed systematic search strategy were first made available on Open Science Framework.1 The developed search strategy was deployed (initial = […]

2 mins
S Harvey (Presenting Author) – The Southwest Cardiothoracic Centre, Plymouth, UK; S Merson – The Southwest Cardiothoracic Centre, Plymouth, UK; B Sieniewicz – The Southwest Cardiothoracic Centre, Plymouth, UK

Introduction: Continuous cardiac monitoring (CCM) is vital for observing patients at risk of arrhythmia. It can, however, restrict mobility and increase the risk of falls and delirium in susceptible patients. Its use should therefore be rationalised and regularly reviewed to ensure ongoing monitoring remains indicated. In our centre, there are currently no guidelines for the […]

2 mins
AA Miyazawa (Presenting Author) – Imperial College London, London, UK; D Keene – Imperial College London, London, UK; AD Arnold – Imperial College London, London, UK; JS Mohal – Imperial College London, London, UK; A Naraen – Imperial College London, London, UK; N Ali – Imperial College London, London, UK; MJ Shun-Shin – Imperial College London, London, UK; DC Lefroy – Imperial College Healthcare NHS Trust, London, UK; PB Lim – Imperial College London, London, UK; FS Ng – Imperial College London, London, UK; M Koa-Wing – Imperial College Healthcare NHS Trust, London, UK; N Qureshi – Imperial College London, London, UK; NWF Linton – Imperial College London, London, UK; NS Peters – Imperial College London, London, UK; P Kanagaratnam – Imperial College London, London, UK; DP Francis – Imperial College London, London, UK; ZI Whinnett – Imperial College London, London, UK

Introduction: Implantable cardioverter defibrillators (ICDs) reduce mortality in people at risk of sudden cardiac death. During ventricular tachycardias (VT), cardiac output is reduced due to fast heart rates reducing diastolic filling time, loss of atrio-ventricular synchrony and loss of bi-ventricular synchrony. Improving haemodynamic status during VT may allow more time for VT to self-terminate and […]

2 mins
CR Redmond (Presenting Author) – St Thomas’ Hospital, London, UK; PI Ihionvien – St Thomas’ Hospital, London, UK

Introduction: Implantable loop recorder (ILR) implantation has become a mainstay for management of infrequent symptoms suspected to be of arrhythmic origin. Since their first documented use in 1990, these devices have seen multiple iterations and are now self-contained injectable systems that can be implanted by non-medical staff with additional training. Cardiac physiologist (CP)-led implant services […]

7

Posters 1

2 mins
KL Murray (Presenting Author) – East Kent Hospitals University Foundation Trust, East Kent, UK

A 76-year-old male attended clinic for routine annual follow up of a dual chamber pacemaker which was implanted just over 2 years prior for bifascicular block and multiple episodes of syncope. Presenting rhythm over the device lifetime had typically been sinus rhythm with <5% VP. The following lead parameters were measured: RV lead impedance – […]

3 mins
CM Mehegan (Presenting Author) – West Suffolk NHS Foundation Trust, Bury St Edmunds, UK

Case background: An 82-year-old male was referred for outpatient device implantation for symptomatic junctional bradycardia. A dual chamber Boston Scientific generator was implanted with active fixation leads secured in the right atrial appendage and right ventricular septum. The procedure was without complication and the device was programmed DDD 50–130 bpm. Implant parameters: R wave 9.8 Mv and […]

2 mins
K Saleh (Presenting Author) – Harefield Hospital, London, UK; J Syan – Chelsea and Westminster NHS Trust, London, UK; M Wright – Chelsea and Westminster NHS Trust, London, UK; S Pearse – Chelsea and Westminster NHS Trust, London, UK; J Barrett – Chelsea and Westminster NHS Trust, London, UK; J Bird – Chelsea and Westminster NHS Trust, London, UK; S Khan – Chelsea and Westminster NHS Trust, London, UK

Introduction: Technological innovations, catalyzed by the COVID-19 pandemic, have opened new avenues for remote monitoring, screening and diagnostics in cardiovascular care. Atrial fibrillation (AF) has a huge healthcare burden within our health service and is a major contributor to presentations to health services, hospitalizations, morbidity and mortality. We identified an opportunity to digitize and enhance our […]

2 mins
M Kuehl – University Hospital of Coventry and Warwickshire, Coventry, UK; S Yusuf – University Hospital of Coventry and Warwickshire, Coventry, UK; T Mahdy (Presenting Author) – University Hospital of Coventry and Warwickshire, Coventry, UK

Introduction: Cardiac arrest in relatively young patients is a difficult presentation to manage, with multiple potential causes. Establishing an accurate diagnosis is crucial and has implications on first-degree relatives. Here we present the case of a 56-year-old female with a first presentation of cardiac arrest, highlighting some of the diagnostic and treatment challenges encountered. Case […]

2 mins
E Kirwan (Presenting Author) – University of Galway, Galway, Ireland; C McIntosh – University of Galway, Galway, Ireland; C MacGilchrist – University of Galway, Galway, Ireland; E Canty – Health Service Executive, Galway, Ireland

Introduction: Atrial fibrillation (AF) is the most common arrhythmia globally in adults and its prevalence increases with age. The incidence of mild cognitive impairment (MIC) also increases with age. Both MCI and AF share important risk factors. Aims: This study aimed to examine the relationship between MCI and AF through a phased approach. Phase one […]

2 mins
S Mizen – Health Innovation Network, London, UK; A Caruso – Health Innovation Network, London, UK; R Jogiya (Presenting Author) – Kingston Hospital, Kingston, UK

Introduction: The NHS Long Term Plan identifies CVD as the single biggest area where lives can be saved. Primary care provides a crucial role in the management of patients at risk of CVD. Offering a programme can help empower and improve confidence and management of high-risk conditions among clinicians. Methods: We held series of monthly […]

2 mins
LF Anderson (Presenting Author) – King’s College Hospital, London, UK; P Khan – King’s College Hospital, London, UK; B Sidhu – Croydon Health Services NHS Trust, Croydon, UK

Background: TriageHF (Medtronic) is a remote monitoring algorithm that stratifies a patient’s risk of a heart failure (HF) event within the next 30 days as high, medium or low, based on integrated cardiac resynchronization therapy (CRT) device diagnostic data. TriageHF remote monitoring became part of standard care at King’s College Hospital in 2021. Physiologists are […]

< 1 min
Amar Alhamdi (Presenting Author) – Alhamdi Heart Clinic, Sulaimanya, Iraq

Background: DC-cardioversion of atrial fibrillation may be immediate or delayed after shock delivery. Objective: To characterize each phenomenon, the immediate or delayed reversion of atrial fibrillation. Patients and methods: Patients with persistent atrial fibrillation who reverted to sinus rhythm with DC-cardioversion were included in this case series study. One group showed immediate reversion and the […]

2 mins
S Toora (Presenting Author) – Essex Cardiothoracic centre, Chelmsford, UK; NT Srinivasan – Essex Cardiothoracic Centre, Basildon, UK; A Sharma – Essex Cardiothoracic Centre, Basildon, UK

Background: Post-atrial fibrillation (AF) ablation clinics are typically in person, whereby 12-lead electrograms (ECG) and/or Holter monitors can detect recurrence. During the COVID-19 pandemic, at our site, nurse-led clinics were telephonic, and timely access to these investigations became difficult. Objective: To determine if the validated smartphone application FibriCheck, which uses photoplethysmography to detect AF, can […]

2 mins
HJ Williams (Presenting Author) – Bristol Heart Institute, Bristol, UK; AK Nightingale – Bristol Heart Institute, Bristol, UK; I Diab – Bristol Heart Institute, Bristol, UK

Introduction: Medical therapy for heart failure with reduced ejection fraction (HfrEF) improves quality of life, reduces heart failure hospitalization and mortality, and reduces the risk of ventricular arrhythmias. International guidelines recommend four key drug classes for all patients with HfrEF. However, many patients do not receive them. Implementing clinical pathways to increase access to HfrEF […]

2 mins
AD Dimitrov (Presenting Author) – Royal Brompton and Harefield Hospital (part of Guys and St. Thomas NHS Foundation Trust), London, UK; SH Haldar – Royal Brompton and Harefield Hospital (part of Guys and St. Thomas NHS Foundation Trust), London, UK

Introduction: Advanced clinical practice (ACP) is an established structured university programme available to registered non-medical clinicians. ACP training prepares those healthcare professionals to safely manage clinical care within both in- and outpatient setting, and incorporates complex clinical decisions and a high degree of autonomy. Aim: To assess the service impact, safety and efficiency of a […]

< 1 min
KJN Nganga (Presenting Author) – UMC, Las Vegas, NV, USA

Atrial fibrillation and COVID 19 are two different diseases, but both are upper body issues. Atrial fibrillation is an upper chamber heart issue, while COVID 19 is an upper respiratory issue. Linked together by their disease factors. Knowing your hearts rhythm and rate is of importance in early detection of atrial fibrillation; just a simple […]

< 1 min
C-Y Chan (Presenting Author) - University Hospitals of Morecambe Bay NHS Foundation Trust, Lancaster, UK; P Aung - University Hospitals of Morecambe Bay NHS Foundation Trust, Lancaster, UK; S Pelton - University Hospitals of Morecambe Bay NHS Foundation Trust, Lancaster, UK; D Ferguson - University Hospitals of Morecambe Bay NHS Foundation Trust, Lancaster, UK; A Shrestha - University Hospitals of Morecambe Bay NHS Foundation Trust, Lancaster, UK

Background: Atrial fibrillation (AF) is a prevalent arrhythmic condition that affects millions of individuals across the globe. Direct current cardioversion (DCCV) is frequently utilized to restore sinus rhythm, but its long-term success rates are not optimal. Recent meta-analysis has concluded pre-treatment with anti-arrhythmic drugs improves acute restoration and maintenance of sinus rhythm after electrical cardioversion. […]

2 mins
FG Sousa (Presenting Author) - Buckinghamshire Healthcare NHS Trust, High Wycombe, UK; S Kaur - Buckinghamshire Healthcare NHS Trust, High Wycombe, UK; N Qureshi - Buckinghamshire Healthcare NHS Trust, High Wycombe, UK; A Khan - Buckinghamshire Healthcare NHS Trust, High Wycombe, UK

Introduction: Atrial fibrillation and heart failure often coexist, and are associated with increased morbidity and mortality. Their temporal association may not always be clear, with clinicians often facing a ‘chicken-or-egg dilemma’. In this cohort of patients with persistent AF and LV dysfunction, electrical cardioversion is often undertaken to elucidate the aetiology of the LV dysfunction […]

Background: Atrial fibrillation (A-Fib) effects over 33.5 million people globally, being one of the most popular causes for hospitalization. Maintaining sinus rhythm and symptom-free patients is the goal post electrophysiology ablation (EP-Ab). Ideally, a preprocedural computed tomography (CT) should be used to assess left atrial (LA) anatomy, pulmonary vein (PV) sizes and to exclude intracardiac […]

8

Posters 2

2 mins
T Woodhead (Presenting Author) - Calderdale and Huddersfield NHS Foundation Trust, Halifax, UK; L Farrar - Calderdale and Huddersfield NHS Foundation Trust, Halifax, UK; S Clegg - Calderdale and Huddersfield NHS Foundation Trust, Halifax, UK; W Veevers - Calderdale and Huddersfield NHS Foundation Trust, Halifax, UK; E Hartley - Calderdale and Huddersfield NHS Foundation Trust, Halifax, UK; H Elmahy - Calderdale and Huddersfield NHS Foundation Trust, Halifax, UK; K Viswanathan - Calderdale and Huddersfield NHS Foundation Trust, Halifax, UK

Background: Recent trial evidence suggests an early rhythm control strategy in managing atrial fibrillation (AF) reduces adverse cardiovascular outcomes. ESC guidelines recommend an integrated approach to AF management, including arrhythmia nurse specialist involvement in follow-up. Published data is limited for initiation and long-term monitoring of patients with AF on rhythm control drugs through an independent […]

2 mins
AWL Li (Presenting Author) - Stanford Cardiovascular Institute, Palo Alto, CA, USA; APH Hnatiuk - Stanford Cardiovascular Institute, Palo Alto, CA, USA; DWS Staudt - Stanford Cardiovascular Institute, Palo Alto, CA, USA; RSF Fernandez - Stanford Cardiovascular Institute, Palo Alto, CA, USA; JAA Ataam Arthur - Stanford Cardiovascular Institute, Palo Alto, CA, USA; IK Karakikes - Stanford Cardiovascular Institute, Palo Alto, CA, USA; MM Mercola - Stanford Cardiovascular Institute, Palo Alto, CA, USA

Introduction: The phospholamban (PLN) cardiomyopathy is a highly prevalent cause of inherited cardiomyopathies in Dutch populations, caused by a single arginine deletion in the phospholamban gene (PLNR14del), which presents with an early-onset of heart failure and spontaneous lethal ventricular arrhythmias leading to sudden cardiac death. Currently, there is still no effective treatment to prevent or […]

2 mins
S Williams (Presenting Author) - Bristol Heart Institute, Bristol, UK; A El-Medany - Bristol Heart Institute, Bristol, UK; C Cowie - The Football Association, London, UK; E Duncan - Bristol Heart Institute, Bristol, UK

Introduction: Sudden cardiac arrest (SCA) in sport is a tragic event. Elite footballers are at increased risk compared with the general population. The risk in non-elite but competitive individuals is unknown. Rapid response to SCA events is critical to ensure a good clinical outcome. At non-elite, competitive levels of football in the United Kingdom (UK), […]

2 mins
J Jagger (Presenting Author) - Mid Yorkshire Hospitals Trust, Wakefield, UK; V Nayar - Mid Yorkshire Hospitals Trust, Wakefield, UK; M Ramzan - Mid Yorkshire Hospitals Trust, Wakefield, UK

Introduction: Optimization of heart failure medications has a vital role in improving the prognosis of patients with heart failure with reduced ejection fraction even after intervention with cardiac resynchronization therapy (CRT). We sought to determine the extent and impact of drug optimization in patients following CRT at our centre. Methods: We conducted a retrospective, observational, […]

2 mins
Authors: N Wijesuriya (Presenting Author) - Kings College, London, London, UK; M Strocchi - Kings College, London, London, UK; V Mehta - Kings College, London, London, UK; F De Vere - Kings College, London, London, UK; S Howell - Kings College, London, London, UK; JM Behar - Kings College, London, London, UK; P Bosco - Guys and St Thomas’s NHS Foundation Trust, London, UK; SA Niederer - Kings College, London, London, UK; CA Rinaldi - Kings College, London, London, UK

Introduction: Leadless left ventricular (LV) endocardial pacing with the WiSE-CRT System (EBR Systems Inc) is a novel treatment in the field of cardiac resynchronization therapy (CRT). The system was designed to provide lateral wall LV pacing (LVP) in response to detection of a right ventricular pacing (RVP) stimulus from a co-implanted device. The result is […]

3 mins
M Giaccardi (Presenting Author) - SMA, Firenze, Italy; B Baldauf - CAU and HS Bremerhaven, Kiel, Germany; S Borov - CAU, Kiel, Germany; EW Lau - RVH, Belfast, Northern Ireland; H Bonnemeier - CAU, HS Bremerhaven, Helios Cuxhaven and Nordenham, Cuxhaven, Germany

Introduction: Conventional right ventricular pacing can cause left ventricular systolic dysfunction, heart failure symptoms and atrial fibrillation in the long run. Early upgrade to biventricular stimulation or physiological stimulation may be able to prevent these adverse outcomes. His bundle pacing (HBP) has several pitfalls which include lack of capture at acceptable thresholds, incremental threshold values […]

2 mins
S Daghem (Presenting Author) - Bristol Heart Institute, Bristol Royal Infirmary, Bristol, UK; B Palash - Bristol Heart Institute (UHBW), Bristol, UK

Case: A 58-year-old male with dual chamber pacemaker implanted 14 years previously for sinus node disease presented with red papular rash and burning pain over pacemaker site. He was initially treated with antibiotics for presumed device relate infection. Normal white cell count (WCC) and C-reactive protein (CRP), with negative blood cultures. Rash resolved during admission. […]

< 1 min
M Patel (Presenting Author) - Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK; J Wilkinson - Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK; S Silva - Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK; I Turner - Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK

Inappropriate implantable cardioverter-defibrillator (ICD) therapies are associated with adverse outcomes. The aim of this study is to determine the frequency and cause of inappropriate therapies in patients under the care of Royal Papworth Hospital NHS Foundation Trust, UK. All patients with ICDs on remote follow-up between January and December 2021 who experienced therapy were included […]

3 mins
S Borov (Presenting Author) - CAU and Klinikum Freising, Kiel, Germany; B Baldauf - CAU and University of Applied Sciences Bremerhaven, Kiel, Germany; M Giaccardi - SMA, Firenze, Italy; EW Lau - RVH, Belfast, Northern Ireland; H Bonnemeier - CAU, University of Applied Sciences Bremerhaven, Helios Cuxhaven and Nordenham, Cuxhaven, Germany

Introduction: In patients eligible for cardiac implantable electronic device (CIED) placement with the need of a high percentage of ventricular pacing, early indication for CIED placement able to deliver cardiac resynchronization therapy (CRT) is advantageous, because it may prevent a pacemaker syndrome (left ventricular ejection fraction deterioration in patients with apicoseptal right ventricular lead placement […]

2 mins
OAJ Jaffery - Queen Mary University of London, Digital Environment Research Institute (DERI), London, UK; RJH Hunter - Barts Health NHS Trust, London, UK; SH Honarbakhsh - Barts Health NHS Trust, London, UK; CR Roney (Presenting Author) - Queen Mary University of London, Digital Environment Research Institute (DERI), London, UK

Background: Structural remodelling is a proposed pathophysiological mechanism in AF, but its impact on electrophysiological parameters remains limited. Personalized computational models include the effects of personalised anatomy and AF remodelling in a framework that can be used to investigate patient-specific AF mechanisms and test treatment response. These models require calibration to electrophysiology data. However, it is […]

< 1 min
A Nowbar (Presenting Author) - Chelsea and Westminster Hospital NHS Foundation Trust, London, UK; SS Gill - Imperial College London, London, UK; S Uruci - Imperial College London, London, UK; D Francis - Imperial College London, London, UK; D Keene - Imperial College London, London, UK

Background: Trials to detect a mortality benefit in heart failure require long follow up periods and large numbers of participants, which is costly and time-consuming. It is quicker and more feasible to assess quality of life. The Minnesota Living With Heart Failure (MLWHF) Questionnaire is one of the most commonly used outcome measures in heart failure […]

2 mins
SL Smith (Presenting Author) - Imperial College London, London, UK; C Coyle - Imperial College Healthcare NHS Trust, London, UK; N Dhutia - New York University Abu Dhabi, Abu Dhabi, United Arab Emirates; P Kanagaratnam - Imperial College Healthcare NHS Trust, London, UK; N Linton - Imperial College London, London, UK

Introduction: We introduced RETRO-mapping as a software for mapping activation during atrial fibrillation (AF). We subsequently suggested features, such as cycle length (CL) and conduction velocity, to detect plane activity. In this work, we suggest an algorithm for automatic classification of wavefronts. We also explore the relationship between CL and degree of organization of activity. […]

Introduction: The unpredictable and sporadic nature of arrhythmias can cause a challenging diagnosis during a single ECG test. Often a more comprehensive method to detect an arrhythmia is necessary. Wearable cardiac devices, such as the CardiacSense watch, have the ability to continuously monitor heart rate. CardiacSense also enables patients to record an on-the-spot ECG when […]

3 mins
PS Stamatakos (Presenting Author) - Croydon University Hospital, London, UK; BS Sidhu - Croydon University Hospital, London, UK; SW Wilson - Croydon University Hospital, London, UK; PA Arumugam - Croydon University Hospital, London, UK; JM Mcnicholas - Croydon University Hospital, London, UK; DD Dedios - Croydon University Hospital, London, UK; GK Kelly - Croydon University Hospital, London, UK; AR Raveendran - Croydon University Hospital, London, UK; HS Shabeeh - Croydon University Hospital, London, UK; RK Kamdar - Croydon University Hospital, London, UK

Background: Conduction system pacing (CSP) can be achieved with His bundle pacing (HBP) or left bundle branch area pacing (LBBAP). Both result in physiological activation of the ventricles, but LBBAP is perceived to be technically easier and result in more reliable sensing, with lower thresholds. Acute and medium-term experience of CSP in district general hospitals […]

2 mins
T Smith (Presenting Author) - Alder Hey Children’s NHS Foundation Trust, Liverpool, UK; L O’Connell - Alder Hey Children’s NHS Foundation Trust, Liverpool, UK; K Spelman - Alder Hey Children’s NHS Foundation Trust, Liverpool, UK; M Bowes - Alder Hey Children’s NHS Foundation Trust, Liverpool, UK

Introduction: Implantable cardiac defibrillators (ICDs) are a lifesaving therapy for children at risk of life-threatening arrhythmias. Often, such children will present with sudden cardiac arrest, and ICDs are vital for secondary prevention of further life-threatening events. If high-risk young patients are identified early, ICDs can ideally be implanted for primary prevention. Method: We performed a […]

2 mins
CM Maciejewski (Presenting Author) - 1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland; KO Ozierański - 1st Chair and Department of Cardiology Medical University of Warsaw, Warsaw; AB Barwiołek - none , Warsaw, Poland; MB Basza - Medical University of Silesia, Katowice, Poland; MC Ciurla - 1st Chair and Department of Cardiology Medical University of Warsaw, Warsaw, Poland; AB Bożym - 1st Chair and Department of Cardiology Medical University of Warsaw, Warsaw, Poland; MJK Krajsman - Department of Medical Informatics and Telemedicine of Medical University of Warsaw, Warsaw, Poland; MM Maciejewska - Medical University of Warsaw, Warsaw, Poland; PL Lodziński - 1st Chair and Department of Cardiology Medical University of Warsaw, Warsaw, Poland; GO Opolski - 1st Chair and Department of Cardiology Medical University of Warsaw, Warsaw, Poland; MG Grabowski - 1st Chair and Department of Cardiology Medical University of Warsaw, Warsaw, Poland; AC Cacko - Department of Medical Informatics and Telemedicine of Medical University of Warsaw, Warsaw, Poland; PB Balsam - 1st Chair and Department of Cardiology Medical University of Warsaw, Warsaw, Poland

Background: Adoption of electronic health records (EHR) improved the availability of medical documentation for research purposes. However, significant proportion of data is in textual information that cannot be utilized for scientific purposes until it is analyzed through manual chart review. Utilization of only structured data from EHR is insufficient for comprehensive cohort characterization and of […]

2 mins
DB Bharucha (Presenting Author) - Milestone Pharmaceuticals, Charlotte, NC, USA; BS Stambler - Piedmont Heart Institute, Atlanta, GA, USA; B Coutu - Centre Hospitalier de l’Université de Montréal, Montréal, QC, Canada; A Holtz - Milestone Pharmaceuticals, Charlotte, NC, USA; S Shardonofsky - Milestone Pharmaceuticals, Montréal, QC, Canada; K Wood - Emory University, Atlanta, GA, USA; JE Ip - Weill Cornell Medicine, New York Presbyterian Hospital, New York, NY, USA

Introduction: There are currently no FDA-approved drug therapies for use in the at-home setting for an acute treatment of sustained supraventricular tachycardia (SVT); therefore, vagal manoeuvres (VM) are recommended in some patients with SVT to increase parasympathetic tone to terminate the arrhythmia. However, the efficacy of VM has not been previously well-reported. Objective/purpose: To determine […]

9
View All Issues

Comprising articles contributed by renowned thought leaders, European Journal of Arrhythmia & Electrophysiology is a peer reviewed, free-to-access, bi-annual journal that aims to disseminate best practice through review articles addressing the most important and salient developments in the arrhythmia and electrophysiology fields in practical terms.

European Journal of Arrhythmia & Electrophysiology
Frequency: Two print issues per year (Summer & Winter); ePub ahead of print throughout the year.
Print ISSN: 2058-3869 Electronic ISSN: 2058-3877

Close Popup